Clinical Report: The Missing Pieces of the Marmoset Genome
Overview
Researchers have assembled a complete genome for the common marmoset, resolving previously missing regions.
Background
The common marmoset is increasingly recognized as a valuable model for studying human diseases due to its genetic proximity to humans and its susceptibility to age-related memory loss. Understanding its genome is crucial for advancing research in neurodegenerative diseases such as Alzheimer's.
Data Highlights
The study produced a complete telomere-to-telomere assembly and three near-complete haplotypes, adding over 88 million bases of previously unresolved sequences.
Key Findings
- The new reference genome covers centromeres, sex chromosomes, and the major histocompatibility complex.
- Seventy percent of chromosomes across the four haplotypes were assembled from telomere to telomere.
- More than 99 percent of each genome was estimated to be complete and accurate.
- Alignment of short-read data from 40 marmosets to the new reference reduced technical artifacts in variant calling.
- Of 81 human loci associated with Alzheimer’s disease, 76 had candidate marmoset counterparts.
Clinical Implications
The complete marmoset genome can improve the accuracy of genomic studies in disease research.
Conclusion
The assembly of the marmoset genome represents a significant advancement in genomic resources for nonhuman primates.
Related Resources & Content
- A Complete Genome for the Common Marmoset - PMC, 2026 -- The Missing Pieces of the Marmoset Genome
- Acta Neuropathologica — Identification of a New NDEL1 Variant Linked to Lissencephaly Highlights the Unique Functions of NDE1 and NDEL1 in Nucleokinesis and Cortical Developmental Disorders
- Acta Neuropathologica — Molecular Distinctions Between Atypical Teratoid/Rhabdoid Tumors with SMARCA4 Mutations and SMARCB1-Deficient Variants
- the analytical scientist — The Early Bird
- Brain — PTEN Modulates Alternative Splicing of Transcripts Linked to Autism Spectrum Disorder in Primary Neuronal Cells
- Genomic Data Sharing Policy Overview | Grants & Funding
- A Complete Genome for the Common Marmoset - PMC
- FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease | FDA
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
